4//SEC Filing
HOBDEN ADRIAN N 4
Accession 0001191076-09-000008
CIK 0000899923other
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 5:30 PM ET
Size
10.4 KB
Accession
0001191076-09-000008
Insider Transaction Report
Form 4
HOBDEN ADRIAN N
Pres. Myriad Pharmaceuticals
Transactions
- Exercise/Conversion
Common Stock
2009-06-08$10.28/sh+29,178$299,950→ 234,071 total - Exercise/Conversion
Incentive Stock Option (right to buy)
2009-06-08−29,178→ 9,726 totalExercise: $10.28Exp: 2015-09-14→ Common Stock (29,178 underlying) - Exercise/Conversion
Common Stock
2009-06-08$12.53/sh+7,980$100,000→ 204,893 total - Exercise/Conversion
Incentive Stock Option (right to buy)
2009-06-08−7,980→ 0 totalExercise: $12.53Exp: 2010-04-20→ Common Stock (7,980 underlying)
Footnotes (2)
- [F1]The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.
- [F2]20% vests annually beginning on the 1st anniversary of the date of the Option Grant.
Documents
Issuer
MYRIAD GENETICS INC
CIK 0000899923
Entity typeother
Related Parties
1- filerCIK 0001191076
Filing Metadata
- Form type
- 4
- Filed
- Jun 7, 8:00 PM ET
- Accepted
- Jun 8, 5:30 PM ET
- Size
- 10.4 KB